Samuel Kaffenberger
Clinical Associate Professor of Urology
Associate Chief Clinical Officer
Urology and Core Educational Lead
Cancer Center Administration
Medical School

Available to mentor
Samuel Kaffenberger
Clinical Associate Professor
  • Center Memberships
  • Recent Publications
    • Manage Your Profile
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      IP16-30 DO TISSUE-BASED BIOMARKERS IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA PERFORM BETTER WHEN DERIVED FROM A METASTATIC SITE COMPARED TO THE PRIMARY?
      Monda S, Vaishampayan U, Kaffenberger S, Triner D, Nallandhighal S, Morgan T, Hafez K, Knuth Z, Singhal U, Gulati S, Palapattu G, Salami S. Journal of Urology, 2025 Apr 10; 213 (5S): e877 DOI:10.1097/01.ju.0001110024.72300.75.30
    • Journal Article
      MP28-03 VALIDATION OF A 15-GENE PROGNOSTIC SIGNATURE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA
      Monda S, Nallandhighal S, Vaishampayan U, Singhal U, Knuth Z, Mehra R, Kaffenberger S, Hafez K, Udager A, Palapattu G, Morgan T, Salami S. Journal of Urology, 2025 Apr 10; 213 (5S): e1004 DOI:10.1097/01.ju.0001110068.14710.ff.03
    • Journal Article
      PD10-06 DETECTION OF GERMLINE VARIANTS IN PATIENTS WITH LOCALIZED AND METASTATIC PROSTATE CANCER THROUGH GUIDELINE-BASED TESTING
      Solorzano MA, Abusamra SM, Quarles J, Luke M, Patel M, Vince R, Jiang R, Volin J, Jacobs MF, Kaffenberger S, Salami SS, Palmbos P, Caram MEV, Palapattu GS, Hollenbeck BK, Merajver SD, Stoffel EM, Hafron J, Morgan TM, Reichert ZR. Journal of Urology, 2025 Apr 10; 213 (5S): e375 DOI:10.1097/01.ju.0001109840.15154.ea.06
    • Journal Article
      PATIENT-DERIVED RENAL CELL CANCER ORGANOIDS AS A MODEL TO ASSESS THERAPEUTIC TARGETS AND TREATMENT RESISTANCE MECHANISMS
      Triner DA, Pham TM, Knuth Z, Nallandhighal S, Monda S, Abusamra S, Dhanasekaran SM, Udager AM, Cotta B, Su F, Madhi H, Kikuchi H, Tran S, Tian J, Hail N, Semerjian A, Hafez KZ, Singhal U, Kaffenberger SD, Nagrath S, Chinnaiyan AM, Keller ET, May A, Morgan TM, Zaslavsky A, Palapattu GS, Vaishampayan U, Merrill NM, Salami SS. Urologic Oncology Seminars and Original Investigations, 2025 Mar 1; 43 (3): 22 DOI:10.1016/j.urolonc.2024.12.056
    • Journal Article
      Do tissue-based biomarkers in metastatic clear cell renal cell carcinoma perform better when derived from a metastatic site?
      Monda S, Vaishampayan UN, Kaffenberger S, Triner D, Nallandhighal S, Morgan TM, Hafez K, Knuth Z, Singhal U, Gulati S, Palapattu GS, Salami SS. Journal of Clinical Oncology, 2025 Feb 20; 43 (5_suppl): 569 - 569. DOI:10.1200/jco.2025.43.5_suppl.569
    • Journal Article
      Validation of a 15-gene prognostic signature in metastatic clear cell renal cell carcinoma.
      Monda S, Nallandhighal S, Vaishampayan UN, Singhal U, Knuth Z, Mehra R, Kaffenberger S, Hafez K, Udager AM, Palapattu GS, Morgan TM, Salami SS. Journal of Clinical Oncology, 2025 Feb 20; 43 (5_suppl): 578 - 578. DOI:10.1200/jco.2025.43.5_suppl.578
    • Journal Article
      Financial Implications of Prostate Magnetic Resonance Imaging Without Contrast
      Pockros B, Davenport M, Mead M, Talwar R, Kaffenberger S, Sekar R, Ibrahim A, Morgan TM. Urology Practice, 2024 Nov 1; 11 (6): 915 - 917. DOI:10.1097/UPJ.0000000000000646
    • Journal Article
      Detection of Germline Variants in Patients with Localized and Metastatic Prostate Cancer through Guideline-Based Testing
      Abusamra SM, Solorzano MA, Quarles J, Luke M, Patel M, Vince Jr R, Jiang R, Volin J, Jacobs MF, Kaffenberger S, Salami SS, Palmbos P, Caram MEV, Hollenbeck BK, Palapattu GS, Merajver SD, Stoffel EM, Hafron J, Morgan TM, Reichert ZR. Urology Practice, 2024 Jun 3; DOI:10.1097/UPJ.0000000000000727